Performance criteria of the post-analytical phase.

Healthcare quality must meet minimum standards to ensure patient safety and effective treatment. Laboratory medicine often lacks clinical outcome data, so it relies on biological variation and technical benchmarks. The post-analytical phase is crucial for translating accurate technical results into clinically meaningful reports. Laboratories differ in how they apply reference intervals, which can affect interpretation. These intervals may improve clinical relevance if tailored to individual physiology and harmonized through consensus. Clinical decision limits offer a more direct approach than reference intervals for patient-specific concerns. Expert knowledge from laboratories can enhance reports by adding procedural guidance. Critically abnormal results require immediate action to reduce mortality risks. The quality of laboratory reports is judged by their impact on clinical decisions and patient outcomes.

This study aims to evaluate the performance criteria of the post-analytical phase in laboratory medicine. It focuses on how technical results are transformed into clinical interpretations. The study highlights the limitations of current reference interval use and the potential benefits of harmonization and optimization. It also explores the role of clinical decision limits in improving interpretation accuracy. The purpose includes identifying gaps in how laboratories provide actionable information. It emphasizes the importance of expert knowledge in guiding clinical follow-up. The study seeks to establish a framework for quality reporting that reflects real-world clinical impact. It aims to improve patient outcomes through better laboratory communication and decision support.

The study reviews existing literature on laboratory quality standards and post-analytical practices. It examines how reference intervals are applied across different laboratories. The researchers analyze the variability in interval use and its clinical implications. They assess the role of biological variation in setting benchmarks. The approach includes comparing clinical decision limits with reference intervals. The study evaluates how expert knowledge is integrated into patient reports. It considers the impact of critical result handling on mortality risk. The methods focus on synthesizing evidence to guide quality improvement in laboratory reporting.

Reference intervals vary between laboratories even when analytical methods are consistent. These intervals may lack individualized relevance without optimization. Harmonization through professional consensus could enhance their clinical utility. Clinical decision limits are more effective than reference intervals for patient-specific concerns. Expert knowledge from laboratories can add procedural guidance to reports. Critically abnormal results require prompt action to reduce mortality risk. The study identifies three key steps in quality interpretation: describing abnormalities, interpreting clinical context, and providing follow-up knowledge. These findings suggest that post-analytical quality is best measured by its impact on clinical management and patient outcomes.

The study concludes that post-analytical quality is best judged by its impact on clinical decisions and patient outcomes. Reference intervals may need optimization and harmonization to improve clinical relevance. Clinical decision limits are more effective than reference intervals for individualized interpretation. Expert knowledge should be integrated into reports to guide clinical follow-up. Prompt action on critical results is essential to minimize mortality risks. The three-step framework for quality interpretation highlights the importance of clear communication. The findings suggest that laboratory reports should reflect both technical accuracy and clinical relevance. The study supports the need for standardized approaches to post-analytical reporting in laboratory medicine.